TMC Life Sciences Berhad, an investment holding company, (0101) Fair Value & Analysis
Healthcare · MY · Market cap 766M MYR
Fair value as of: Jun 24, 2026
Analysis
TMC Life Sciences Berhad, an investment holding company, (0101) currently trades at 0.4500 MYR, while our model-based Fair Value estimate is 0.0500 MYR — implying the stock looks roughly 88.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; and research and development activities, as well as providing fertility consultancy, laboratory, and embryology services. TMC Life Sciences Berhad was founded in 1994 and is based in Petaling Jaya, Malaysia. The company is a subsidiary of Sasteria (M) Pte. Ltd.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is TMC Life Sciences Berhad, an investment holding company, (0101) undervalued?
What is the fair value of 0101?
What is the quality score of 0101?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.